Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden flag Sweden · Delayed Price · Currency is SEK
13.72
+0.02 (0.15%)
Aug 13, 2026, 5:29 PM CET

Xspray Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
12.196.432.131.772.180.66
Revenue Growth
185.59%206.87%-93.40%1357.20%232.32%-51.91%
Gross Profit
12.196.432.131.772.180.66
Operating Income
-138.73-156.91-287.04-181.73-133.07-97.95
Net Income
-159.44-171.44-285.52-179.67-131.67-96.7
Earnings Per Share
-3.86-4.46-8.62-6.76-6.25-5.03
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
179.91153.75208.24166.3120.17271.88
Total Debt
147.3148.39128.2236.812.133.23
Net Cash (Debt)
32.65.3580.02129.5118.04268.65
Net Cash Growth
--93.31%-38.21%9.70%-56.06%-16.23%
Net Cash Per Share
0.780.142.414.875.6013.96

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-150.35-193.16-222.37-203.28-110.18-51.61
Capital Expenditures
---4.38-2.69-24.47-1.31
Free Cash Flow
-150.35-193.16-226.75-205.97-134.65-52.92
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-1138.47%-2439.52%-13694.70%-572.08%-6104.27%-14931.90%
Pretax Margin
-1309.00%-2667.07%-13629.48%-565.63%-6039.91%-14740.55%
Profit Margin
-1309.64%-2668.69%-13636.70%-565.69%-6039.91%-14740.50%
FCF Margin
-1233.76%-3003.16%-10818.10%-648.37%-6176.38%-8067.07%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-3.762.022.6214.5314.53
PS Ratio
263.43204.10734.4439.35587.662002.49